Josh Kosowsky, MD, FACEP; Natalie Kreitzer, MD, MS; Jose I. Suarez, MD, FNCS, FANA, FAAN


Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

Onye J. Ononogbu, PharmD, BCOP; Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP, FAAN; Ana Maria Lopez, MD, MPH, MACP, FRCP; Susan Fugett, MSW, LISW-S, OSW-C, CSW-G

  Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

Colleen Cotton, MD, FAAD; Raj Chovatiya, MD, PhD, FAAD

Addressing Challenges in the Management of HS in Special Populations

Best Practice in the Multidisciplinary Care of the Patient with HS

Robert Z. Orlowski, MD, PhD; Elisabet E. Manasanch, MD, MHSc; Jing Christine Ye, MD, MSc

Clinical Vignettes: Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Charu Aggarwal, MD, MPH; David R. Gandara, MD; Lynette M. Sholl, MD; Ignacio I. Wistuba, MD

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Heather A. Wakelee, MD, FASCO; Lyudmila Bazhenova, MD; Kristin Higgins, MD; Brendon Stiles, MD

  Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

Jessica Ailani, MD, FAHS, FAAN; Richard S. Isaacson, MD; Stephen Krieger, MD, FAAN; Rory Abrams, MD; Karthikeyan M. Arcot, MD; Cynthia E. Armand, MD; Patricia K. Coyle, MD; Gayatri Devi, MD, MS, FAAN; 

2022 4th Annual International Congress on the Future of Neurology

Johanna P. Contreras, MD, MSc, FACC, FAHA, FHFSA; Melvin R. Echols, MD, FACC, FHFSA, FASPC

Clinical Consultations: Improving Outcomes By Addressing Health Care Disparities in Heart Failure Care

Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older

Antibody-Drug Conjugates in Gynecological Cancer: Review of the Clinical Data

Grace Cherry, MSN, RN, NP; Beth Sandy, MSN, CRNP; Laura S. Wood, MSN, RN, OCN; Patricia Mangan, MSN, RN, CRNP, APRN-BC; Kimberly Podsada, MSN, NP-C; Rowena “Moe” Schwartz, PharmD, BCOP,
FHOPA



Community Practice Connections™: 6th Annual School of Nursing Oncology

David R. Gandara, MD; Roy S. Herbst, MD, PhD; Natasha B. Leighl, MD, MMSc, FRCPC, FASCO; Heather A. Wakelee, MD

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

Anthony J. Aldave, MD; Clara C. Chan, MD, FRCSC, FACS, DABO

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing Corneal Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis

Hope S. Rugo, MD, FASCO; Giuseppe Curigliano, MD, PhD; Özge Gümüşay, MD

  Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

Srdan Verstovsek, MD, PhD; Lucia Masarova, MD; Jeanne Palmer, MD; Abdulraheem Yacoub, MD   

Medical Crossfire®:  Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

John Mascarenhas, MD; Heinz Gisslinger, MD; Kathryn Johnson, DNP, MSc, FNP-BC; Naveen Pemmaraju, MD


4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Edward B. Garon, MD, MS; Rebecca Heist, MD, MPH; Solange Peters, MD, PhD; Jacob Sands, MD

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Bruce Ovbiagele, MD MSc MAS MBA MLS; Alexis N. Simpkins, MD, PhD, MSCR, FAHA; Charles Esenwa, MD, MS

Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?

Tahseen Mozaffar, MD; Allison Foley, MS, CGC; Perry B. Shieh, MD, PhD

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

Scott Urquhart, PA-C, DFAAPA; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It?

Marwan N. Sabbagh, MD, FAAN; Richard S. Isaacson, MD; Lon Schneider, MD, MS

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

Steven Horwitz, MD; Ellen J. Kim, MD; Alison Moskowitz. MD

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

Shakeel Modak, MD, MRCP; Araz Marachelian, MD, MS

Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases

Stephen Krieger, MD, FAAN; Erin Longbrake, MD, PhD

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

Scott Urquhart, PA-C, DFAAPA; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Kim Zuber, PA-C

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Lynette M. Sholl, MD; Justin F. Gainor, MD; Fred R. Hirsch, MD, PhD, FASCO

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

J. William Harbour, MD; Richard D. Carvajal, MD; Alison H. Skalet, MD, PhD

Medical Crossfire®: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD, DFAPA; Larry Culpepper, MD; Corine de Boer, MD, PhD; Rif S. El-Mallakh, MD; C. Neill Epperson, MD; Marlene P. Freeman, MD; Nassir Ghaemi, MD, MPH; Joseph F. Goldberg, MD; Benjamin D. Greenberg, MD, PhD; Mark B. Hamner, MD; Brian Hurley, MD, MBA, DFASAM; Alana Iglewicz, MD; Jonathan M. Meyer, MD; Nidal Moukaddam, MD, PhD; Sonya Norman, PhD; Edward Nunes, MD; Dhakshin Ramanathan, MD, PhD; Christopher Schneck, MD; M. Katherine Shear, MD; Michael E. Thase, MD; J. Eric Vance, MD; David B. Yaden, PhD; Rachel Yehuda, PhD; Sidney Zisook, MD

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

Abbey Kaler, MS, APRN, FNP-C; Kelly Leonard, MSN, APRN, FNP-BC

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

(CME Credit) Expert Illustrations & Commentaries™: Visualizing Corneal Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis

Daniel C. Brennan, MD, FACP; Sam Kant, MD MRCPI FASN

Clinical ShowCase™: Optimizing Care from Start to Finish for Patients with ESRD Requiring Renal Transplantation

DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We and Where Are We Going?

Community Practice Connections™: Bridging Clinical Gaps and Disparities in Care in TNBC

John J. Miller, MD; Leslie Citrome, MD, MPH; Amber Hoberg, APRN, MSN, PMHNP-BC

Tardive Dyskinesia: Moving Management Forward

NSCLC TUMOR BOARD: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings

Kathleen N. Moore, MD, MS; Ritu Salani MD, MBA

Oncology Consultations®: How Do The Experts Utilize PARP Inhibitors in Ovarian Cancer Across Lines of Care?

Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency

Expert Illustrations & Commentaries™: Roles and Rationales for BCMA-Directed Therapies in Multiple Myeloma

PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies

PER® Postgame: Breaking Down the Latest Data and Updates in Anemia of Chronic Kidney Disease – Fall 2021 Nephrology Meeting Takeaways

BURST CME™: Deciphering Clinical Trial Endpoints Amidst an Advent of Novel Therapies for Low- to High-Risk MDS

Advances In™ Marginal Zone Lymphoma: Applying New Developments to Practice

Arun Srivastava, PhD; Hanny Al-Samkari, MD

Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape

Kelley Robert Branch, MD, MS; Sonia Anand, MD, PhD; Schuyler Jones, MD; Christian Thomas Ruff, MD, MPH

Community Practice Connections: Making the Most of Effective Antithrombotic Strategies in Patients with CAD and PAD

Sagar Lonial, MD, FACP; Meletios A. Dimopoulos, MD

Advances in™: Application of Proteasome Inhibitor Therapies Across the MM Disease Spectrum

Krishna Komanduri, MD; Juan Felipe Ramirez, APRN-BC

Show Me Your Care Plan! Managing Adverse Events Associated with CAR T-Cell Therapies for Oncology Nurses

Oncology Consultations®: Critical Conversations for Treating sAML in the Outpatient Setting

PER® Postgame™: Reporting the Latest Global Updates Across the Treatment of Breast Cancer

Proteolysis-Targeting Chimera (PROTAC) Therapy for Cancer

Kristin Highland, MD, MSCR; Deborah Jo Levine MD FCCP

Expert Illustrations and Commentaries: Finding the Best Path Forward in PAH Management - A Focus on Prostacyclin Therapy

Andre H. Goy, MD; Roy S. Herbst, MD, PhD; Claudine Isaacs, MD; Benjamin P. Levy, MD; John L. Marshall, MD; Eileen M. OReilly, MD

3rd Annual Precision Medicine Symposium: An Illustrated Tumor Board

Oncology Best Practice™ Series: Key Questions for the Community on the Detection and Treatment of MRD

Burst Expert Illustrations & Commentaries™: The Impact of Targeted IL-17 Inhibition on the Treatment for Moderate to Severe Plaque Psoriasis

Dawn Laney, MS, CGC, CCRC: Manesh R. Patel, MD

BURST Clinical Consultations: Addressing Long-term Cardiac and Renal Outcomes in Fabry Disease

David I Quinn, MD, MBBS, PhD, FRACP, FACP

Advances In™: Testing and Treatment of Metastatic CRPC with PARP Inhibitors

Advances In™ Hematology: New Therapeutic Options to Treat AL Amyloidosis

Clinical Vignette Series: How Can We Be More Strategic in Treatment Planning for Patients with ALL?

3rd Annual International Congress on the Future of Neurology®

Anthony Mato, MD, MSCE; Nitin Jain, MD; William G. Wierda, MD, PhD

Community Practice Connections™: How Are We Meeting the Needs of Patients With CLL Across Lines of Care?

Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors

Neal Shore, MD, FACS; Robert Dreicer, MD, MS, MACP, FASCO; Celestia S. Higano, MD, FACP; Daniel P. Petrylak, MD

Community Practice Connections™: How the Experts Approach Testing and Treatment When Utilizing PARP Inhibitors for mCRPC

Community Practice Connections™: Navigating the Latest Evidence to Optimize Utilization of Novel Therapies in R/R CML

Clinical Vignette: Managing Multiple Myeloma From Newly Diagnosed to Relapsed/Refractory Settings: An Expert Case-Based Discussion

Optimizing Use of T-Cell–Engaging Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia

Joseph Tauber, MD; John Sheppard, MD, MMSc, FACS

(CME Credit) Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED

(COPE Credit) Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED

Francis S. Mah, MD; Karolinne Rocha, MD, PhD

(COPE Credit) Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis

(CME/CNE Credit) Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Neil M. Bressler, MD; Jennifer I. Lim, MD, FARVO

(COPE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

(CME/CNE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Jennifer Dvorak, MSN, FNP-BC; Beth Sandy, MSN, CRNP

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

Neal Shore, MD, FACS; Scott Tagawa, MD, MS, FACP

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

Arshad M. Khanani MD, MA; Jennifer I. Lim MD, FARVO, FASRS

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

Elias Jabbour, MD; Hagop M. Kantarjian, MD

Community Practice Connections™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Joyce O’Shaughnessy, MD; Balazs Halmos, MD, MS; Cathy Eng, MD, FACP, FASCO;  Brian I. Rini, MD, FASCO; Saad Z. Usmani, MD, MBA, FACP; Nilanjan Ghosh, MD, PhD

  Community Practice Connections™: ASCO Direct Highlights: Practice-Changing Data From the Leading Oncology Conference

Jason J. Luke, MD, FACP; Evan J. Lipson, MD; Yana G. Najjar, MD; Daniel Olson, MD; Sapna Patel, BA, MD

  Medical Crossfire ®: Addressing the Top 10 Clinical Challenges in Melanoma

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP, OCN 

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

Ticiana A. Leal, MD; Jordyn P. Higgins, PharmD, BCOP; Ashley Rollins, BSN, OCN

Patient, Provider, and Caregiver Connection™: Shedding a Light on the Patient Journey with KRAS Mutated Lung Cancer

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Matthew Galsky, MD, FASCO; Kevin Kalinsky, MD, MS; Samuel J. Klempner, MD

Community Practice Connections™: 6th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Arshad M. Khanani, MD, MA; Peter K. Kaiser, MD; Anat Loewenstein, MD, MHA; Christina Y. Weng, MD, MBA, FASRS

Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Neil M. Bressler, MD; Sophie J. Bakri, MD, MBA; Jennifer I. Lim, MD, FARVO

Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Mile Brujic, OD, FAAO; Marc R. Bloomenstein, OD, FAAO; Selina McGee, OD, FAAO

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

Naval G. Daver, MD ; Guillermo Garcia-Manero, MD ; Uma Borate, MD, MS ; Jacqueline S. Garcia, MD 

Continuing Education

Latest News